Relaxin decreases the severity of established hepatic fibrosis in mice

Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial

(2012) John R Teerlink et al.   LANCET

Relaxin Signals through a RXFP1-pERK-nNOS-NO-cGMP-Dependent Pathway to Up-Regulate Matrix Metalloproteinases: The Additional Involvement of iNOS

(2012) Bryna Suet Man Chow et al.   PLoS One

H3 Relaxin Demonstrates Antifibrotic Properties via the RXFP1 Receptor

(2011) Mohammed Akhter Hossain et al.   BIOCHEMISTRY

Relaxin remodels fibrotic healing following myocardial infarction

(2011) Chrishan S Samuel et al.   LABORATORY INVESTIGATION

Antifibrotic Properties of Relaxin:In VivoMechanism of Action in Experimental Renal Tubulointerstitial Fibrosis

(2010) Tim D. Hewitson et al.   ENDOCRINOLOGY

Relaxin Reduces Fibrosis in Models of Progressive and Established Hepatic Fibrosis

(2009) Robert G. Bennett et al.   Annals of the New York Academy of Sciences

Relaxin and its role in the development and treatment of fibrosis

(2009) Robert G. Bennett   Translational Research

Fibrosis and Cirrhosis Reversibility – Molecular Mechanisms

(2008) Roben G. Gieling et al.   Clinics in Liver Disease

Relaxin Ameliorates Fibrosis in Experimental Diabetic Cardiomyopathy

(2008) Chrishan S. Samuel et al.   ENDOCRINOLOGY

Relaxin inhibits renal myofibroblast differentiation via RXFP1, the nitric oxide pathway, and Smad2

(2008) Ishanee Mookerjee et al.   FASEB JOURNAL

Mechanisms of Hepatic Fibrogenesis

(2008) Scott L. Friedman   GASTROENTEROLOGY

Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver

(2008) Scott L. Friedman   PHYSIOLOGICAL REVIEWS